ProKidney Corp.PROKNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank40
3Y CAGR-19.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-19.4%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 25.15% |
| 2023 | -36.82% |
| 2022 | 701.10% |
| 2021 | 48.03% |
| 2020 | 43.83% |
| 2019 | 0.00% |